Good morning, everyone. Damian Garde here, filling in for Ed Silverman as the working week tilts toward almost over. The sun has crept into view after a sodden Tuesday, which will hopefully brighten your routine of meetings, deadlines, and requisite office small talk. To get you started, please find a few items of interest. And, as always, if you hear anything interesting, do let us know.
AbbVie (ABBV) is accused of using old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira, STAT tells us. According to a lawsuit filed by the California insurance commissioner, AbbVie hired registered nurses to act as “ambassadors” to visit patients at home and help with administering the drug, but instead were used to ensure that prescriptions were continually refilled.